Patient-reported outcomes of upadacitinib versus abatacept in rheumatoid arthritis

被引：0
|
作者：
Thorley, Jennifer
机构：
来源：
LANCET RHEUMATOLOGY | 2022年 / 4卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E531 / E531
页数：1
相关论文
共 50 条
  • [21] Sensitivity of measures of patient reported outcomes following treatment with abatacept in patients with rheumatoid arthritis
    Wells, G.
    Li, T.
    Maxwell, L.
    Maclean, R.
    Tugwell, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 607 - 607
  • [22] Impact of Upadacitinib Versus Abatacept on Individual Disease Outcomes in Pts With Rheumatoid Arthritis and Inadequate Responses to Biologic DMARDS
    van Vollenhofen, R.
    Rubbert-Roth, A.
    Hall, S.
    Xavier, R.
    Shmagel, A.
    Song, Y.
    Anyanwu, S.
    Strand, V
    SWISS MEDICAL WEEKLY, 2023, 153 : 27S - 27S
  • [23] Upadacitinib improves patient-reported outcomes vs placebo or adalimumab in patients with rheumatoid arthritis: results from SELECT-COMPARE
    Strand, Vibeke
    Tundia, Namita
    Bergman, Martin
    Ostor, Andrew
    Durez, Patrick
    Song, In-Ho
    Enejosa, Jeffrey
    Schlacher, Casey
    Song, Yan
    Fleischmann, Roy
    RHEUMATOLOGY, 2021, 60 (12) : 5583 - 5594
  • [24] Impact of Upadacitinib versus Abatacept on Individual Disease Outcomes in Patients with Rheumatoid Arthritis and Inadequate Responses to Biologic DMARDs
    van Vollenhoven, Ronald
    Rubbert-Roth, Andrea
    Hall, Stephen
    Xavier, Ricardo
    Shmagel, Anna K.
    Song, Yanna
    Anyanwu, Samuel
    Strand, Vibeke
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 2812 - 2814
  • [25] Upadacitinib monotherapy improves patient-reported outcomes in rheumatoid arthritis: results from SELECT-EARLY and SELECT-MONOTHERAPY
    Strand, Vibeke
    Tundia, Namita
    Wells, Alvin
    Buch, Maya H.
    Radominski, Sebastiao C.
    Camp, Heidi S.
    Friedman, Alan
    Suboticki, Jessica L.
    Dunlap, Kendall
    Goldschmidt, Debbie
    Bergman, Martin
    RHEUMATOLOGY, 2021, 60 (07) : 3209 - 3221
  • [26] Early Real-World Effectiveness of Upadacitinib in Rheumatoid Arthritis Using Patient-Reported Outcomes Collected via Mobile Application
    Harrold, Leslie
    Zueger, Patrick
    Nowell, William Benjamin
    Blachley, Taylor
    Lakin, Paul
    Curtis, David
    Stradford, Laura
    Venkatachalam, Shilpa
    Tundia, Namita
    Patel, Pankaj
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 2656 - 2658
  • [27] UPADACITINIB IMPROVES PATIENT-REPORTED OUTCOMES IN PATIENTS WITH RHEUMATOID ARTHRITIS AND INADEQUATE RESPONSE TO METHOTREXATE: RESULTS FROM SELECT-COMPARE
    Strand, Vibeke
    Bergman, Martin
    Tundia, Namita
    Ostor, Andrew
    Durez, Patrick
    Song, In-Ho
    Enejosa, Jose Jeffrey
    Schlacher, Casey
    Song, Yan
    Fleischmann, Roy
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 738 - 739
  • [28] Golimumab Improves Patient-Reported Outcomes In Patients With Active Rheumatoid Arthritis
    Dasgupta, B.
    Bertin, P.
    Settas, L.
    Fonseca, J. E.
    Wolff, V.
    Yao, R.
    Govoni, M.
    Vastesaeger, N.
    Weng, H. H.
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S209 - S209
  • [29] A comparative study of patient-reported functional outcomes in acute rheumatoid arthritis
    Zochling, Jane
    Stucki, Gerold
    Grill, Eva
    Braun, Juergen
    JOURNAL OF RHEUMATOLOGY, 2007, 34 (01) : 64 - 69
  • [30] DO PATIENT-REPORTED OUTCOMES IN RHEUMATOID ARTHRITIS REFLECT DISEASE ACTIVITY?
    Ben Abdelghani, K.
    Boussaa, H.
    Miladi, S.
    Sellami, M.
    Souabni, L.
    Kassab, S.
    Chekili, S.
    Fazaa, A.
    Laatar, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1118 - 1119
12345